BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38106528)

  • 1. Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national survey.
    Nakano N; Nakasone H; Fuji S; Shinohara A; Suzuki R; Utsunomiya A; Eto T; Morishima S; Ikegame K; Kakinoki Y; Matsuoka KI; Mori Y; Suehiro Y; Uchida N; Ito A; Doki N; Ozawa Y; Kanda J; Kanda Y; Fukuda T; Atsuta Y; Ogata M
    Lancet Reg Health West Pac; 2023 Nov; 40():100902. PubMed ID: 38106528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation.
    Kawano N; Yoshida S; Kawano S; Kuriyama T; Tahara Y; Toyofuku A; Manabe T; Doi A; Terasaka S; Yamashita K; Ueda Y; Ochiai H; Marutsuka K; Yamano Y; Shimoda K; Kikuchi I
    J Clin Exp Hematop; 2018 Sep; 58(3):107-121. PubMed ID: 30089749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
    Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation.
    Forcina A; Lorentino F; Marasco V; Oltolini C; Marcatti M; Greco R; Lupo-Stanghellini MT; Carrabba M; Bernardi M; Peccatori J; Corti C; Ciceri F
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1476-1482. PubMed ID: 29501780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of a Humanized CCR4 Antibody (Mogamulizumab) on Patients with Aggressive-Type Adult T-Cell Leukemia-Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation.
    Kawano N; Kuriyama T; Yoshida S; Kawano S; Yamano Y; Marutsuka K; Minato S; Yamashita K; Ochiai H; Shimoda K; Ishikawa F; Kikuchi I
    J Clin Exp Hematop; 2017; 56(3):135-144. PubMed ID: 28331127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect.
    Shiratori S; Yasumoto A; Tanaka J; Shigematsu A; Yamamoto S; Nishio M; Hashino S; Morita R; Takahata M; Onozawa M; Kahata K; Kondo T; Ota S; Wakasa K; Sugita J; Koike T; Asaka M; Kasai M; Imamura M
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):817-23. PubMed ID: 18541202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma.
    Utsunomiya A
    Front Microbiol; 2019; 10():2235. PubMed ID: 31681185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative analysis between autologous and allogeneic hematopoietic stem cell transplantation in 114 adult patients with acute lymphoblastic leukemia in long-term follow-up].
    Bao YS; Jiang EL; Wang M; Wang H; Huang Y; Wei JL; Yang DL; Feng SZ; Qiu LG; Han MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1325-9. PubMed ID: 19099637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
    Tanaka Y; Nakasone H; Yamazaki R; Sato K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Oshima K; Tanihara A; Nishida J; Yoshikawa T; Nakatsura T; Sugiyama H; Kanda Y
    Cancer Res; 2010 Aug; 70(15):6181-92. PubMed ID: 20647322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outcomes of 33 patients with anaplastic large cell lymphoma treated after hematopoietic stem cell transplantation].
    Lu N; Li XF; Dong YJ; Wang YN; Fu XR; Wu YM; Li YH; Wang MH; Li NN; Ren HY; Wang Z; Zhang MZ; Wu XX; Hu LD; Liu Y; Huang WR
    Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):117-122. PubMed ID: 32135627
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for T lymphoblastic leukemia/lymphoma].
    Luo L; Jiao Y; Yang P; Li Y; Huang WY; Ke XY; Zou DH; Jing HM
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):388-394. PubMed ID: 37550188
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study on allogeneic with autologous hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in the era of TKIs: a systematic review and meta-analysis.
    Wei H; Kuang P; Liu T
    Ann Hematol; 2020 Nov; 99(11):2619-2628. PubMed ID: 32960314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China.
    Gu ZY; Dong YJ; Fu XR; Li NN; Liu Y; Wu XX; Wang YN; Li YH; Ren HY; Zhang MZ; Li XF; Wang MH; Wu YM; Liu DH; Wang Z; Hu LD; Huang WR
    Chin Med J (Engl); 2021 Jun; 134(13):1584-1592. PubMed ID: 34133361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.
    Tamai Y; Hasegawa A; Takamori A; Sasada A; Tanosaki R; Choi I; Utsunomiya A; Maeda Y; Yamano Y; Eto T; Koh KR; Nakamae H; Suehiro Y; Kato K; Takemoto S; Okamura J; Uike N; Kannagi M
    J Immunol; 2013 Apr; 190(8):4382-92. PubMed ID: 23475215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma with HTLV-1-associated myelopathy.
    Sakamoto H; Itonaga H; Sawayama Y; Kojima A; Chiwata M; Fujioka M; Kitanosono H; Horai M; Miyazaki T; Shiraishi H; Imaizumi Y; Yoshida S; Hata T; Yamano Y; Miyazaki Y
    Int J Hematol; 2021 May; 113(5):765-769. PubMed ID: 33423163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma.
    Yamasaki R; Miyazaki Y; Moriuchi Y; Tsutsumi C; Fukushima T; Yoshida S; Taguchi J; Inoue Y; Matsuo E; Imaizumi Y; Imanishi D; Fujimoto T; Tsushima H; Honda S; Hata T; Tsukasaki K; Tomonaga M
    Leukemia; 2007 Jun; 21(6):1212-7. PubMed ID: 17410191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.
    Harashima N; Kurihara K; Utsunomiya A; Tanosaki R; Hanabuchi S; Masuda M; Ohashi T; Fukui F; Hasegawa A; Masuda T; Takaue Y; Okamura J; Kannagi M
    Cancer Res; 2004 Jan; 64(1):391-9. PubMed ID: 14729650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors.
    Yoshimitsu M; Fuji S; Utsunomiya A; Nakano N; Ito A; Ito Y; Miyamoto T; Suehiro Y; Kawakita T; Moriuchi Y; Nakamae H; Kanda Y; Ichinohe T; Fukuda T; Atsuta Y; Kato K;
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):718-722. PubMed ID: 31821886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
    Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.